Menu
Mobile menu

Beverly A. Rzigalinski, PhD, MS

Beverly A. Rzigalinski

Beverly A. Rzigalinski, PhD, MS

Professor for Pharmacology
Campus: 
Virginia Campus
Office: 

Garvin Building

Department/Discipline: 
Phone: 
540-231-1744
Email: 
brzigali [at] vcom.vt.edu

Current Research Projects

  • Biochemical effects of OMM at the cellular level
  • Cerium Oxide nanoparticles in the treatment of traumatic brain injury

Publications

Year Published Faculty Citation PMID
2014

Rzigalinski BA, Sholar A, Cook J, Klein L, Puri S, Hockey K. Cerium oxide nanoparticles for the treatment and prevention of stroke and cardiovascular disease. Provisional Patent 13/744815; filed 2014.

2014

Rzigalinski BA, Clark AM. Anti-inflammatory, radioprotective and longevity-enhancing capabilities of cerium oxide nanoparticles. United States Patent 8,747,907. 10 June 2014.

2013

Hockey KS, Hubbard WB, Sajja VS, Scholar CA, Thorpe C, Vandevord PJ, Rzigalinski BA. A new model for mild blast injury utilizing Drosophila melanogaster. Biomedical Sciences Instrumentation. 2013; 49:124-40.

23686192
2013

Thorpe CS, Sholar C, Hockey KS, Rzigalinski BA. Structural evidence for cytoskeletal changes following traumatic brain injury in mixed organotypic cultures. J. Neurotrauma. 2013; 30(15):A-49.

2013

Hampton CE, Thorpe CN, Sholar CA, Rzigalinski BA, VandeVord PJ. A novel bridge wire model of blast traumatic brain injury - biomed 2013. Biomed Sco Instrum. 2013; 49:312-9. PMID: 23686215.

23686215
2013

Sholar C, Sajja S, Hubbard B, Hockey KS, VandeVord PJ, Rzigalinski BA. A new model for mild blast head injury utilizing Drosophila melanogaster. J. Neurotrauma. 2013; 30(15): A-97.

2012

Balbuena P, Li W, Rzigalinski B, Ehrich M. Malathion/oxon and lead acetate increase gene expression and protein levels of transient receptor potential canonical channel subunits TRPC1 and TRPC4 in rat endothelial cells of the blood-brain barrier. Int. J. Toxicology. 2012 Jun; 31(3):238-49. PMID: 22674931.

22674931
2011

VanLaeken AH, Ardito TC, Hockey KS, Rzigalinski B, Whiting MD. (-)-Epigallocatechin gallate improves outcome following in vitro and in vivo traumatic brain injury [abstract]. In: Abstracts from the 29th Annual National Neurotrauma Symposium; 2011 Jul 10-13; Hollywood Beach, FL: Journal of Neurotrauma. 2011 Jun:A66. Abstract no. P174.

2011

Dillon CE, Billings M, Hockey KS, DeLagarze L, Rzigalinski BA. Cerium oxide nanoparticles protect against MPTPinduced dopaminergic neurodegeneration in a mouse model for Parkinson's Disease [abstract]. In: Nanotechnology 2011: Biosensors, Instruments, Medical, Environment and Energy. Technical Proceedings of 2011 NSTI Nanotechnology Conference and Expo; 2011 Jun 16-16; Boston, MA. CRC Press; 2011. Volume 3:451-4.  

2011

Rzigalinski BA, Meehan K, Whiting M.D., Dillon C, Hockey K, and Brewer M. Chapter 6: Antioxidant nanoparticles. In: Nanomedicine in Health & Disease. RJ Hunter, ed., New York, NY: Science Publishers; c.2011. p. 100-21.